Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 408


A case of a cerebral cavernous malformation of the third ventricle that caused the syndrome of inappropriate secretion of antidiuretic hormone.

Sasaki T, Hayashi N, Tomura N, Tsuji E, Okada H, Kuwata T.

Surg Neurol Int. 2017 Apr 26;8:53. doi: 10.4103/sni.sni_1_17. eCollection 2017.


Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407).

Shitara K, Doi T, Nagano O, Fukutani M, Hasegawa H, Nomura S, Sato A, Kuwata T, Asai K, Einaga Y, Tsuchihashi K, Suina K, Maeda Y, Saya H, Ohtsu A.

Gastric Cancer. 2017 May 2. doi: 10.1007/s10120-017-0720-y. [Epub ahead of print]


Removal of a malignant cystic brain tumor utilizing pyoktanin blue and fibrin glue: Technical note.

Hayashi N, Sasaki T, Tomura N, Okada H, Kuwata T.

Surg Neurol Int. 2017 Feb 20;8:24. doi: 10.4103/2152-7806.200578. eCollection 2017.


Fibroblast-led cancer cell invasion is activated by epithelial-mesenchymal transition through platelet-derived growth factor BB secretion of lung adenocarcinoma.

Neri S, Miyashita T, Hashimoto H, Suda Y, Ishibashi M, Kii H, Watanabe H, Kuwata T, Tsuboi M, Goto K, Menju T, Sonobe M, Date H, Ochiai A, Ishii G.

Cancer Lett. 2017 Jun 1;395:20-30. doi: 10.1016/j.canlet.2017.02.026. Epub 2017 Mar 9.


Intraoperative peritoneal lavage cytology offers prognostic significance for gastric cancer patients with curative resection.

Higaki E, Yanagi S, Gotohda N, Kinoshita T, Kuwata T, Nagino M, Ochiai A, Fujii S.

Cancer Sci. 2017 May;108(5):978-986. doi: 10.1111/cas.13219. Epub 2017 May 22.


Endogenous and exogenous miR-520c-3p modulates CD44-mediated extravillous trophoblast invasion.

Takahashi H, Ohkuchi A, Kuwata T, Usui R, Baba Y, Suzuki H, Chaw Kyi TT, Matsubara S, Saito S, Takizawa T.

Placenta. 2017 Feb;50:25-31. doi: 10.1016/j.placenta.2016.12.016. Epub 2016 Dec 14.


Flap choice for closure of open window thoracotomy: a response to the author of the article entitled "the omentum flap for empyema treatment: indications and disadvantages".

Shinohara S, Chikaishi Y, Kuwata T, Takenaka M, Oka S, Hirai A, Imanishi N, Kuroda K, Tanaka F.

J Thorac Dis. 2016 Dec;8(12):E1777-E1779. doi: 10.21037/jtd.2016.12.55. No abstract available.


Safety and reproducibility of virtual-assisted lung mapping: a multicentre study in Japan.

Sato M, Kuwata T, Yamanashi K, Kitamura A, Misawa K, Imashimizu K, Kobayashi M, Ikeda M, Koike T, Kosaka S, Fukai R, Sekine Y, Isowa N, Hirayama S, Sakai H, Watanabe F, Nagayama K, Aoyama A, Date H, Nakajima J.

Eur J Cardiothorac Surg. 2017 May 1;51(5):861-868. doi: 10.1093/ejcts/ezw395.


Complete Resection of Thymic Sarcomatoid Carcinoma Through Total Aortic Arch Replacement.

Oka S, Taira A, Shinohara S, Kuwata T, Takenaka M, Chikaishi Y, Hirai A, Uramoto H, Nishimura Y, Tanaka F.

Ann Thorac Surg. 2016 Dec;102(6):e557-e559. doi: 10.1016/j.athoracsur.2016.05.095.


Middle mediastinal thymic carcinoma with cystic findings in radiologic images: a case report.

Shinohara S, Kuroda K, Kuwata T, Takenaka M, Oka S, Chikaishi Y, Hirai A, Imanishi N, Tanaka F.

Surg Case Rep. 2016 Dec;2(1):129. Epub 2016 Nov 7.


Total or partial vertebrectomy for lung cancer invading the spine.

Oka S, Matsumiya H, Shinohara S, Kuwata T, Takenaka M, Chikaishi Y, Hirai A, Imanishi N, Kuroda K, Yamada S, Uramoto H, Nakamura E, Tanaka F.

Ann Med Surg (Lond). 2016 Oct 15;12:1-4. eCollection 2016 Dec.


Achievement of Cure with Gefitinib in Advanced Lung Adenocarcinoma Harboring an Activating EGFR Mutation: A Case Report.

Kuwata T, Yoneda K, Kobayashi K, Oyama R, Matumiya H, Shinohara S, Takenaka M, Oka S, Chikaishi Y, Imanishi N, Kuroda K, Tanaka F.

Case Rep Oncol. 2016 Oct 4;9(3):565-567. eCollection 2016 Sep-Dec.


Clinicopathological significance of caveolin-1 expression by cancer-associated fibroblasts in lung adenocarcinoma.

Shimizu K, Kirita K, Aokage K, Kojima M, Hishida T, Kuwata T, Fujii S, Ochiai A, Funai K, Yoshida J, Tsuboi M, Ishii G.

J Cancer Res Clin Oncol. 2017 Feb;143(2):321-328. doi: 10.1007/s00432-016-2285-2. Epub 2016 Oct 22.


Changes in the tumor microenvironment during lymphatic metastasis of lung squamous cell carcinoma.

Ikemura S, Aramaki N, Fujii S, Kirita K, Umemura S, Matsumoto S, Yoh K, Niho S, Ohmatsu H, Kuwata T, Kojima M, Ochiai A, Betsuyaku T, Tsuboi M, Goto K, Ishii G.

Cancer Sci. 2017 Jan;108(1):136-142. doi: 10.1111/cas.13110. Epub 2017 Jan 21.


Enhanced antibody-mediated neutralization of HIV-1 variants that are resistant to fusion inhibitors.

Alam M, Kuwata T, Shimura K, Yokoyama M, Ramirez Valdez KP, Tanaka K, Maruta Y, Oishi S, Fujii N, Sato H, Matsuoka M, Matsushita S.

Retrovirology. 2016 Sep 27;13(1):70.


Complete resection for pleomorphic lung cancer with a high serum IL-6 level: a case report.

Oka S, Matsumiya H, Shinohara S, Kuwata T, Takenaka M, Chikaishi Y, Hirai A, Imanishi N, Kuroda K, Uramoto H, Tanaka F.

Surg Case Rep. 2016 Dec;2(1):101. doi: 10.1186/s40792-016-0232-8. Epub 2016 Sep 23.


The ratio of cancer cells to stroma after induction therapy in the treatment of non-small cell lung cancer.

Goto M, Naito M, Saruwatari K, Hisakane K, Kojima M, Fujii S, Kuwata T, Ochiai A, Nomura S, Aokage K, Hishida T, Yoshida J, Yokoi K, Tsuboi M, Ishii G.

J Cancer Res Clin Oncol. 2017 Feb;143(2):215-223. doi: 10.1007/s00432-016-2271-8. Epub 2016 Sep 17.


Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients.

Kawazoe A, Kuwata T, Kuboki Y, Shitara K, Nagatsuma AK, Aizawa M, Yoshino T, Doi T, Ohtsu A, Ochiai A.

Gastric Cancer. 2017 May;20(3):407-415. doi: 10.1007/s10120-016-0631-3. Epub 2016 Sep 14.


Circulating Tumor Cells as an Indicator of Postoperative Lung Cancer: A Case Report.

Kuwata T, Yoneda K, Kobayashi K, Oyama R, Matumiya H, Shinohara S, Takenaka M, Oka S, Chikaishi Y, Inanishi N, Kuroda K, Tanaka F.

Am J Case Rep. 2016 Sep 15;17:663-5.


Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung.

Naito M, Aokage K, Saruwatari K, Hisakane K, Miyoshi T, Hishida T, Yoshida J, Masato S, Kojima M, Kuwata T, Fujii S, Ochiai A, Sato Y, Tsuboi M, Ishii G.

Lung Cancer. 2016 Oct;100:53-62. doi: 10.1016/j.lungcan.2016.07.024. Epub 2016 Jul 27.


Supplemental Content

Loading ...
Support Center